Skip to main content
TipRanks
Go Ultimate75% OFF

Shinnihonseiyaku Co., Ltd. (4931) AI Stock Analysis

0 Followers
JP:4931

Shinnihonseiyaku Co., Ltd.

(TSE/TYO:4931)

Select Model
Rating:84Outperform
Price Target:JPY 2,387.00â–²(17.99% Upside)
Action:reiterated
Date:11/14/26

Shinnihonseiyaku Co., Ltd. earns a strong overall score, primarily driven by its pristine, debt-free balance sheet, exceptional gross margins, and highly appealing valuation. Supported by a solid dividend yield and bullish technical momentum across all major moving averages, the stock presents a compelling fundamental and technical profile.

Positive Factors
Strong margins and improving profitabilityHigh gross margins and a sustained improvement in operating profitability indicate strong economics in the company’s health-product portfolio. If maintained, this margin structure can support reinvestment in product development and marketing while providing resilience against moderate cost pressure.
Negative Factors
Uneven cash conversion and lower latest-year FCFPersistent operating cash flow coverage below net income suggests working-capital or timing headwinds can absorb part of accounting earnings. The sharp 2026 free-cash-flow decline also reduces near-term funding flexibility and makes cash generation less predictable for investment or distributions.

Shinnihonseiyaku Co., Ltd. (4931) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%JP:4931+0.54%EWJ+14.66%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 42.94B
Dividend Yield
2.92%
Average Volume (3M)
50.93K
Price to Earnings (P/E)
12.2
Beta (1Y)
0.32
Revenue Growth
5.63%
EPS Growth
37.65%
Country
Japan
Employees
316
Sector
Consumer Cyclical
Sector Strength
61
Industry
Specialty Retail

Shinnihonseiyaku Co., Ltd. Business Overview & Revenue Model

Company Description

Shinnihonseiyaku Co., Ltd. is a Japanese-headquartered company, established in 1992, that specializes in providing cosmetics, pharmaceuticals, and health foods both domestically and in international markets. The company's operations are structured in...

How the Company Makes Money

Shinnihonseiyaku makes money primarily by selling its health-related products (e.g., supplements and wellness products) to end customers and through distribution partners, generating revenue from product sales. Key revenue streams typically include (...

Shinnihonseiyaku Co., Ltd. Financial Statement Overview

Summary

Shinnihonseiyaku demonstrates a highly robust financial profile, driven by steady top-line growth, a pristine debt-free balance sheet, and exceptional gross margins. Despite occasional cash flow volatility, the business consistently and effectively converts net income into free cash flow.

Income Statement

85Very Positive

Balance Sheet

95Very Positive

Cash Flow

75Positive
Financial statement breakdown
BreakdownTTMSep 2026Sep 2025Sep 2024Sep 2023Sep 2022
Income Statement
Total Revenue42.56B43.45B41.14B40.04B37.65B36.11B
Gross Profit33.55B34.09B32.58B31.53B29.98B29.07B
EBITDA4.96B5.50B5.15B4.49B4.19B3.95B
Net Income3.29B3.51B2.55B2.79B2.39B2.36B
Balance Sheet
Total Assets29.03B30.08B28.44B27.28B25.50B23.86B
Cash, Cash Equivalents and Short-Term Investments18.59B19.47B18.12B16.34B15.52B14.35B
Total Debt349.00M076.00M253.00M446.00M1.84B
Total Liabilities4.79B5.13B5.63B5.48B5.84B5.94B
Stockholders Equity24.24B24.95B22.81B21.79B19.66B17.92B
Cash Flow
Free Cash Flow4.63B2.60B4.63B1.93B3.37B2.25B
Operating Cash Flow4.69B2.73B4.69B2.10B3.47B2.29B
Investing Cash Flow-1.79B-1.73B-1.79B-382.00M-208.00M-496.00M
Financing Cash Flow-2.10B-1.18B-2.10B-902.00M-2.10B-1.09B

Shinnihonseiyaku Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price2023.00

Price Trends

50DMA1992.48Positive
100DMA1980.37Positive
200DMA1974.50Positive

Market Momentum

MACD10.30Negative
RSI53.06Neutral
STOCH58.54Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4931, the sentiment is Positive. The current price of 2023.00 is above the 20-day moving average (MA) of 2006.15, above the 50-day MA of 1992.48, and above the 200-day MA of 1974.50, indicating a bullish trend. The MACD of 10.30 indicates Negative momentum. The RSI at 53.06 is Neutral, neither overbought nor oversold. The STOCH value of 58.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4931.

Shinnihonseiyaku Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:4931 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4931JP:493184OutperformJPY 43.30B12.21―2.92%5.63%37.65%
JP:219AJP:219A71OutperformJPY 65.44B-91.94――――
JP:7679JP:767969NeutralJPY 30.40B8.03―1.88%8.08%-15.52%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
JP:3349JP:334960NeutralJPY 520.98B16.15―1.25%8.99%3.61%
JP:2796JP:279643NeutralJPY 5.98B59.95―2.75%7.64%―
JP:190AJP:190A38UnderperformJPY 3.38B-2.18―――24.21%

* Consumer Cyclical Sector Average

Performance Comparison

-50%0%50%JP:4931JP:2796JP:3349JP:7679JP:190AJP:219ADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4931 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4931Shinnihonseiyaku Co., Ltd.2023.009.810.49%
JP:2796Pharmarise Holdings Corp.509.00-10.03-1.93%
JP:3349COSMOS Pharmaceutical Corporation6545.00-919.91-12.32%
JP:7679Yakuodo Holdings Co., Ltd.1540.00-534.59-25.77%
JP:190AChordia Therapeutics Inc.43.00-58.00-57.43%
JP:219AHeartseed, Inc.2854.001139.0066.41%

Shinnihonseiyaku Co., Ltd. Corporate Events

Shinnihonseiyaku Reports Fiscal 2026 Sales and Profit Growth

Nov 11, 2026

Shinnihonseiyaku is engaged in healthcare and cosmetics businesses, with Slimore Coffee and Fun and Health among the products or brands named in the release.For the fiscal year ended September 2026, net sales rose 5.6% year over year to ¥43,455 milli...

Shinnihonseiyaku Reports Fiscal 2026 Sales and Profit Growth

Nov 11, 2026

Shinnihonseiyaku Co., Ltd. reported consolidated results for the fiscal year ended September 30, 2026, with net sales of ¥43,455 million, up 5.6% year on year. Operating profit rose 8.2% to ¥5,176 million, ordinary profit increased 6.7% to ¥5,202 mil...

Shinnihonseiyaku Reports Fiscal 2026 Growth, Raises Year-End Dividend Forecast

Nov 11, 2026

Shinnihonseiyaku reported fiscal-year net sales of ¥43,450 million, operating profit of ¥5,257 million, ordinary profit of ¥5,294 million and net profit of ¥3,300 million for the year ended September 30, 2026. Compared with the previous fiscal year,...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026